✦ LIBER ✦

The rate of progression of Parkinson's disease

✍ Scribed by Guy V. Sawle

Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 134 KB
Volume: 31
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410310216

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Measuring the rate of progression of Par

Measuring the rate of progression of Parkinson's disease over a 5-year period with β-CIT SPECT

✍ Walter Pirker; Iris Holler; Willibald Gerschlager; Susanne Asenbaum; Georg Zetti 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 1 views

## Abstract Recent imaging studies suggest a rapid degeneration of the dopaminergic system in early Parkinson's disease (PD), followed by a slowing of the degenerative process in advanced disease. In the present study, a group of early‐stage PD patients underwent three sequential [^123^I]β‐CIT SPEC

Application of the unified Parkinson's d

Application of the unified Parkinson's disease rating scale in progressive supranuclear palsy: Factor analysis of the motor scale

✍ Esther Cubo; Glenn T. Stebbins; Lawrence I. Golbe; Annette V. Nieves; Sue Leurga 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 25 KB 👁 2 views

Rate of clinical progression in Parkinso

Rate of clinical progression in Parkinson's disease. A prospective study

✍ Anette Schrag; Richard Dodel; Annika Spottke; Bernhard Bornschein; Uwe Siebert; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 1 views

## Abstract Few prospective data on the clinical progression of Parkinson's disease (PD) in patient groups outside treatment trials in selected patients are available, and controversy exists on the rate of clinical disease progression with advancing disease. In this study, we investigated the rate

Subthalamic nucleus neuronal firing rate

Subthalamic nucleus neuronal firing rate increases with Parkinson's disease progression

✍ Michael S. Remple; Courtney H. Bradenham; C. Chris Kao; P. David Charles; Joseph 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB

Parkinson's disease is a neurodegenerative disorder characterized by progressive loss of dopaminergic cells in the central nervous system, in particular the substantia nigra, resulting in an unrelenting loss of motor and nonmotor function. Animal models of Parkinson's disease reveal hyperactive neur

Clinical measures of progression in Park

Clinical measures of progression in Parkinson's disease

✍ Werner Poewe 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

## Abstract Despite all recent advances in symptomatic therapy Parkinson's disease (PD) continues to be a relentlessly progressive neurodegenerative disorder. Therefore therapies that will slow or hold disease progression are a major medical unmet need in PD. Clinical measures of disease progressio

Rating impairment and disability in Park

Rating impairment and disability in Parkinson's disease: Evaluation of the unified Parkinson's disease rating scale

✍ Dr. J. J. van Hilten; A. D. van der Zwan; A. H. Zwinderman; R. A. C. Roos 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB 👁 1 views

## Abstract Although the Unified Parkinson's Disease Rating Scale (UPDRS) is widely used to monitor disease progression and drug efficacy, no attempts have been made to evaluate its scientific and clinical quality. Poor clinical sensibility of items in the activities of daily living (ADL) section a